What is the recommended treatment for adenoid cystic carcinoma (ACC) of the nasal septum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Adenoid Cystic Carcinoma of the Nasal Septum

Complete surgical resection with negative margins followed by postoperative radiation therapy is the recommended treatment for adenoid cystic carcinoma of the nasal septum to maximize survival and reduce local recurrence rates. 1

Surgical Management

  • Complete surgical resection with negative margins is crucial for long-term survival and may require resection of adjacent structures to achieve clear margins 1
  • The surgical approach should be determined based on tumor location, extent, and involvement of surrounding structures, potentially requiring combined approaches (endoscopic, open, or craniofacial) to achieve complete resection 2
  • If facial nerve branches or other major named nerves are found to be encased or grossly involved by the tumor, they should be resected to achieve negative margins 1
  • Achieving negative margins is particularly important as positive margins significantly increase the risk of local recurrence (18% vs 5% for negative margins) 3

Radiation Therapy

  • Postoperative radiation therapy should be offered to all patients with resected adenoid cystic carcinoma, even with negative margins, due to the high risk of microscopic residual disease 1, 3
  • A total dose of 60 Gy to the tumor bed is recommended, supplemented to 66 Gy for patients with positive margins 3
  • Intensity-modulated radiation therapy may offer improved local tumor control while reducing toxicity to surrounding critical structures 1, 4
  • Field size and dose adequacy are critical factors in preventing local recurrence, with fields exceeding 8×8 cm and doses exceeding 45 Gy showing significantly better local control 5

Treatment Considerations for Advanced Disease

  • For tumors with skull base invasion or extensive local spread, a multidisciplinary approach combining anterior cranial surgery, endoscopic intranasal surgery, and/or transpalatal surgery may be required 2
  • Perineural invasion, particularly of named nerves, is an adverse prognostic factor and should be addressed in treatment planning 3
  • Despite effective local therapy with surgery and radiation, approximately one-third of patients develop distant metastases, most commonly to the lungs 3, 6

Follow-up and Surveillance

  • Regular follow-up is essential due to the high risk of local recurrence and distant metastasis 1
  • Follow-up should include clinical examination, endoscopic evaluation, and imaging studies (MRI for local recurrence, CT chest for lung metastases) 1
  • Long-term follow-up for at least 10 years is necessary due to the risk of late recurrence 1, 6

Management of Recurrent Disease

  • For small local recurrences, treatment options include surgical resection, stereotactic radiation therapy, or a combination of surgery and radiation therapy 1
  • Regional recurrence should be managed by radical neck dissection if resectable 1
  • For patients with limited metastatic disease, local ablative treatments may be considered 1

Common Pitfalls and Caveats

  • Underestimating the extent of disease due to perineural spread is a common pitfall 1
  • Insufficient follow-up duration can lead to overlooking late recurrences, as local failures can occur even 5+ years after treatment 3, 6
  • Despite excellent local control with combined surgery and radiation (70-86% at 5 years), distant metastases remain a significant challenge, occurring in 25-38% of patients 7, 6
  • The 5-year overall survival rate for sinonasal adenoid cystic carcinoma ranges from 62-86%, but this drops significantly to 17% after development of distant metastasis 6

References

Guideline

Treatment of Adenoid Cystic Carcinoma of the Nose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Primary Treatment Approach for Nasopharyngeal Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Radiation therapy in adenoid-cystic carcinoma.

International journal of radiation oncology, biology, physics, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.